Summary
A 27 year old male with metastatic testicular carcinoma was treated with cisplatin, vinblastine, and bleomycin (PVB) chemotherapy. After receiving a cumulative dose of 500 mg/m2 of cisplatin, he developed severe nausea and vomiting and had clinical evidence of a cisplatin-induced peripheral neuropathy. His vomiting resolved five weeks after discontinuation of cisplatin. We believe this case represents the first report of gastric autonomic neuropathy induced by cisplatin.
Similar content being viewed by others
References
Chabner B: Platinum complexes. In: Pharmacologic Principles of Cancer Treatment. WB Saunders, Philadelphia, 1982, pp 309–321
Einhorn LH, Donohue J: Cis-diaminedichloroplatinum vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293–298, 1977
Einhorn LH, Williams SD: Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer 46:1339–1344, 1980
Taylor MH, Depetrillo AD, Turner AR: Vinbastine, bleomycin and cisplatin in malignant germ cell tumors of the ovary. Cancer 56(6):1341–1349, 1985
Rozenczweig M, Von Hoss DD, Slavik M, Muggia FM: Cisdiamminedichloroplatinum (II): A new anticancer drug. Ann Intern Med 86:803–812, 1977
Schilsky RL, Anderson T: Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. Ann Intern Med 90:929–931, 1979
Blachley JD, Hill JB: Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 95:628–632, 1981
Yagoda A, Watson RC, Kemeny N, Grabstald H, Whitmore Jr WF: Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer. Cancer 41:2121–2130, 1978
Einhorn LH, Furnas BE, Powell N: Combination chemotherapy of disseminated testicular carcinoma with cisplatinum, vinblastine and bleomycin (Abstr). Proc Amer Assoc Cancer Res/Proc Amer Soc Clin Oncol 17:249, C-13, 1976
Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozenczweig M, Young RC, Muggia FM: Toxic effects of cisdichlorodiammineplatinum (11) in man. Cancer Treat Rep 63:1527–1531, 1979
Ostrow S, Hahn D, Wiernik PH, Richards RD: Ophthalmologic toxicity after cis-dichlorodiammineplatinum (II) therapy. Cancer Treat Rep 62:1591–1594, 1978
Walsh TJ, Clark AW, Parhad IM, Green WR: Neurotoxic effects of cisplatin therapy. Arch Neurol 39:719–720, 1982
Berman IJ, Mann MP: Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year old man. Cancer 45:764–766, 1980
Mead GM, Arnold AM, Green JA, Macbeth FR, Williams CJ, Whitehouse JM: Epileptic seizures associated with cisplatin administration. Cancer Treat Rep 66:1719–1722, 1982
Kedar A, Cohen ME, Freeman AI: Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum (II) treatment: a case report. Cancer Treat Rep 62:819–821, 1978
Ashraf M, Scotchel PL, Krall JM, Flink EB: Cis-platinum induced hypomagnesemia and peripheral neuropathy. Gyn Oncology 16:309–318, 1983
Thompson SW, Davis LE, Kornfeld M, Hilgers RD, Standefer JD: Cisplatin neuropathy: clinical, electrophysiologic, morphologic and toxologic studies. Cancer 54:1269–1275, 1984
Roelofs RI, Hrushnesky W, Rogin J, Rosenberg L: Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 34:934–938, 1984
Mollman JE, Glover DJ, Hogan WM, Freman RE: Cis-platin neuropathy: risk factors and a possible protective agent (Abstr). Neurology 35 (Suppl. 1):80, 1985
Rosenfeld CS, Broder LE: Cisplatin-induced autonomic neuropathy. Cancer Treat Rep 68:659–660, 1984
Kroop SH, Long W, Alavi A, Hansell JR: Effect of water and fat on gastric emptying of solid meals. Gastroent 77:997–999, 1979
Bradley WG, Lassman LP, Pearce GW, Walton JN: The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci 10:107–131, 1970
Aisner J, Weiss HD, Chang P, Wiernik PH: Orthostatic hypotension during combination chemotherapy with vincristine (NSC-67574). Cancer Chemother Rep 58:927–930, 1974
Roca E, Bruera E, Politi PM, Barugel M, Cedaro L, Carraro S, Chacon RD: Vinca alkaloid-induced cardiovascular autonomic neuropathy. Cancer Treat Rep 69:149–151, 1985
Albibi R, McCallum RW: Metoclopramide: Pharmacology and clinical application. Ann Intern Med 98:86–95, 1983
Baldessarini RJ: Drugs and the treatment of psychiatric disorders. In: Goodman and Gillman's The Pharmacological Basis of Therapeutics. Gillman AG, Goodman LS, Gillman A (eds) Macmillan Publishing Co., New York, 1980, pp 403
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cohen, S.C., Mollman, J.E. Cisplatin-induced gastric paresis. J Neuro-Oncol 5, 237–240 (1987). https://doi.org/10.1007/BF00151227
Issue Date:
DOI: https://doi.org/10.1007/BF00151227